Tableau de bord de la cohorte

La mission du GP2 est de mieux comprendre l’architecture génétique de la maladie de Parkinson (MP) par le génotypage de groupes de patients différents et l’étude des formes soulevant une forte suspicion de cause monogénique de la MP. En soutien à cette mission, nous constituons des cohortes différentes dans le monde en collaborant et en partageant ouvertement les données, les processus et les résultats. Le tableau de bord ci-dessous présente les étapes que nous avons franchies jusqu’à présent. Consultez régulièrement cette page car les données sont mises à jour sur une base trimestrielle.

Total des données mondiales

0
Emplacements uniques
0
Cohortes
0
Echantillons prévus
0
Echantillons terminés

Last Updated: August 10, 2022 | Original design by GP2 Hackathon 2021 Team: Mary Makarious, Kajsa Brolin, Yeajin Song, and Anastasia Illarionova.

Showing 10 of 238 cohort studies.

ProtectMove - Institute of Neurogenetics, University of Lübeck

Institute of Neurogenetics, University of Luebeck | Luebeck, Germany
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 1,950 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 2,900 Expected
Total Samples
Total Samples

0 Completed out of 4,850 Expected

ProtectMove - University of Sciences and Technology, Pakistan

University of Sciences and Technology, Pakistan | Bannu, Pakistan
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 1,950 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 2,900 Expected
Total Samples
Total Samples

0 Completed out of 4,850 Expected

PUKBB

Imperial College London | London, United Kingdom
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 1,300 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 300 Expected
Total Samples
Total Samples

0 Completed out of 1,600 Expected

QPP

Griffith University | Brisbane, Australia
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 1,400 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 1,300 Expected
Total Samples
Total Samples

0 Completed out of 2,700 Expected

Quantitative MRI for Anatomical Phenotyping in Parkinson's Disease

University College London | London, United Kingdom
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 114 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 140 Expected
Total Samples
Total Samples

0 Completed out of 254 Expected

Quebec Parkinson's Network

University of Calgary/McGill University | Calgary, Canada
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 3,000 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 100 Expected
Total Samples
Total Samples

0 Completed out of 3,100 Expected

RAPSODI

University College London | London, United Kingdom
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 1,281 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 268 Expected
Total Samples
Total Samples

0 Completed out of 1,549 Expected

RBM

INSERM, FRENCH INSTITUTE OF HEALTH AND MEDICAL RESEARCH | Paris, France
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 5,500 Expected
Non-PD Samples
Non-PD Samples

0 Completed out of 600 Expected
Total Samples
Total Samples

0 Completed out of 6,100 Expected

REasons for Geographic and Racial Differences in Stroke (REGARDS) Project

University of Alabama Birmingham | Alabama, United States
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

0 Completed out of 1,000 Expected
Non-PD Samples
Non-PD Samples

5,370 Completed out of 1,000 Expected
Total Samples
Total Samples

5,370 Completed out of 2,000 Expected
Ancestry Breakdown for Samples Completed
Show

S4

Michael J. Fox Foundation | Pittsburgh, United States
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
Case Samples

46 Completed out of 60 Expected
Non-PD Samples
Non-PD Samples

15 Completed out of 21 Expected
Total Samples
Total Samples

61 Completed out of 81 Expected
Ancestry Breakdown for Samples Completed
Show

Demande d’ensemble de données auprès de l’AMP-PD

Une fois que le GP2 a terminé le génotypage d’une cohorte, l’intégralité des données est partagée par le biais de la plateforme sécurisée AMP® PD. Il est obligatoire de s’inscrire pour demander l’accès aux données.

Soumettre une cohorte

Si vous souhaitez collaborer avec l’équipe du GP2, veuillez nous contacter pour soumettre une cohorte ou obtenir de plus amples renseignements sur la procédure à suivre pour devenir membre.

Rencontrez les membres du GP2 du monde entier

Découvrez les membres de notre organisation dont la contribution, notamment en termes d’échantillons et de données, nous permet de poursuivre nos travaux de recherche.